학술논문

Brief Report: Risk of Recurrent Interstitial Lung Disease From Osimertinib Versus Erlotinib Rechallenge After Symptomatic Osimertinib-Induced Interstitial Lung Disease
Document Type
Article
Source
In: JTO Clinical and Research Reports. (JTO Clinical and Research Reports, April 2024, 5(4))
Subject
Language
English
ISSN
26663643